TreatSMA

Powerchair choices – our experiences with the Tiny Trax

14/09/2018

Deciding on which powerchair to get for your child, especially their first real one, can feel like a daunting task. A lot of SMA children who have the ability to control a powerchair from a young age start off with a Whizzybug which is a small motorised powerchair suitable for ages 2-5 (approximately), it gives them their first real taste of freedom and independence and the ability to join in and play with friends and family. It also prepares them for the next step in the powerchair world.

Prime Minister asked about Spinraza

13/09/2018

During yesterday’s Questions Time, Mary Glindon MP asked the Prime Minister about access to Spinraza.

TreatSMA advocates for universal newborn screening for SMA

11/09/2018

This week we submitted our comments to the NHS consultation on newborn screening for spinal muscular atrophy. We were shocked to learn that NHS argues against introducing this procedure, and we strongly objected to their views.

TreatSMA has responded to draft nusinersen guidance

09/09/2018

We have submitted our comments to the draft NICE guidance on nusinersen.

SMA community rallies nationwide to demand access to Spinraza treatment

08/09/2018

Yesterday, we stood demanding the right for the SMA community to access the only treatment, Spinraza, for this devastating condition that currently holds the title of the biggest genetic killer of children under 2.

Come and join the protests today!

07/09/2018

Today we the SMA Community are protesting against health policies that threaten to deprive our children and ourselves of Spinraza, the only effective treatment for SMA.

September 7th TreatSMA protests against NICE decision

05/09/2018

On Friday 7th September TreatSMA and the community will stand alongside each other and hold a protest against the proposed decision to not recommend the life-saving drug Spinraza for treating children and adults.

Nusinersen EAP will close for newly diagnosed babies from November

22/08/2018

Biogen has informed us that the Nusinersen Expanded Access Programme will close for new patients on 1 November 2018, even as those currently in the programme will continue without changes.